<DOC>
	<DOCNO>NCT02346318</DOCNO>
	<brief_summary>The randomize control multicenter clinical study compound Kushen Injection reduce radiotherapy related adverse reaction lung cancer phase Ⅳ clinical trials，The main purpose evaluate effect compound Kushen Injection prevent reduce radiotherapy related adverse reaction . The participant clinical trial patient lung cancer need thoracic radiotherapy . In clinical trial , one group participant give compound Kushen Injection chemoradiotherapy , another group give chemoradiotherapy . The period trial 18 month .</brief_summary>
	<brief_title>The Randomized Controlled Clinical Trial Kushen Injection</brief_title>
	<detailed_description>Patients lung cancer need thoracic radiotherapy enrol trial , seprated randomly two group , KS injection group treat chemoradiotherapy plus KS injection ; contral group treat chemoradiotherapy . After 6 month observation , The rate incidence degree adverse reaction cause redioterapy ; completion rate radiotherapy ; clinical Symptoms ; Qof pulmonary function test etc . evaluate .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Before start study , All patient fully understood reseach must sign informed consent To age 18 75 year old , gender The lung cancer diagnosis must prove pathology According RECIST ( version 1.1 ) , At least 1 objectively measurable Tumor lesion ( iconography : CT , MRI ) , assessable lesion measure accurately , maximum diameter least 10mm ( Malignant lymph node CT scan short diameter less least 15 mm ) Eastern Cooperative Oncology Group ( ECOG ) performance status less equal 2 Lung function FEV1 least 1Land 50 % A normal value The function organ basically normal : ANC 1.5*10^9/L , Platelet count 100*10^9/L , Hb 9.0g/dl , BIL normal level less 1.5*ULN , AST ( SGOT ) , ALT ( SGPT ) less 2.5*ULN ( less 5*ULN , liver metastasis ) , SCr le 1.5*ULN The expect survival tme must 6 month . Lung mediastinal receive radiotherapy ever treat Compound Kushen Injection within 2weeks Pregnancy lactation woman Patients severe , uncontrolled organic lesion infection , decompensated heart , lung , kidney failure lead tolerance chemotherapy Participating within last 30 day participate clinical trial Hypersensitiveness kind trial regime Had history serious Psychological Psychiatric disorder , Drug addiction Alcohol dependence Estimating compliance patient participate clinical trial insufficient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>Adverse Effect</keyword>
	<keyword>Dermatitis Eczema</keyword>
</DOC>